Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Centrexion Therapeutics received early financing of $8.8M on 2013-12-02.
| Series | Round size | Date |
|---|---|---|
| Series A | $8.8M | 12/2013 |
| Series B | $14.7M | 12/2013 |
| Convertible Note | $10.5M | 03/2016 |
| Convertible Note | $6.9M | 04/2016 |
| Debt Financing | $17M | 04/2016 |
| Convertible Note | $11.2M | 06/2016 |
| Series C | $47.6M | 12/2016 |
| Series D | $67M | 01/2018 |
| Series Unknown | $40.5M | 10/2020 |
| Investors | Security type |
|---|---|
| InterWest Partners | Series C |
| Quan Capital 泉创资本 | Series D |
| New Enterprise Associates (NEA) | Series D |
| InterWest Partners | Series D |
| ArrowMark Partners | Series D |
| Eli Lilly | Series Unknown |
| Exome Asset Management | Series Unknown |
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Recro Pharma Inc. | - | $94.6M | 255 | - |
| Aclaris Therapeutics | - | $18.7M | 60 | - |
| Cara Therapeutics | - | $7.1M | 84 | - |
| Pharmion | - | - | 417 | - |
| Ardelyx | - | $333.6M | 86 | - |
| MabVax Therapeutics | - | $1.6M | 11 | - |
| CerSci Therapeutics | - | $10.0M | 18 | - |
| Aurinia Pharmaceuticals | - | $235.1M | 33 | - |
| Cerexa Inc. | - | $1.3M | 29 | - |
Zippia gives an in-depth look into the details of Centrexion Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Centrexion Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Centrexion Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Centrexion Therapeutics. The data presented on this page does not represent the view of Centrexion Therapeutics and its employees or that of Zippia.
Centrexion Therapeutics may also be known as or be related to CENTREXION THERAPEUTICS CORP, Centrexion, Centrexion Corp, Centrexion Therapeutics and Centrexion Therapeutics Corp.